CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

WANBURY LTD.

NSE : WANBURYBSE : 524212ISIN CODE : INE107F01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE247.25-10.55 (-4.09 %)
PREV CLOSE () 257.80
OPEN PRICE () 262.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20577
TODAY'S LOW / HIGH ()240.00 262.55
52 WK LOW / HIGH ()132.55 325
NSE246.89-11.49 (-4.45 %)
PREV CLOSE() 258.38
OPEN PRICE () 257.51
BID PRICE (QTY) 246.89 (200)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 180870
TODAY'S LOW / HIGH() 240.00 262.48
52 WK LOW / HIGH ()131.2 323.53
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1988

Management Info :

- Chairman - Managing Director

Registered Office :

Address : B S E L Tech Park,B - Wing, 10th Floor, Sector 30 A,Opp. Vashi Railway Station, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone : 022-67942222 / 71963222

Website : www.wanbury.com

Registrar's Details : Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, NSE, Luxembourg
NEWS
24Mar Wanbury to launch two new products
Wanbury is all set to launch two new products, for formulation (Branded..
06Mar Wanbury informs about press release
Pursuant to Regulation 30 of SEBI Listing Regulations, Wanbury has infor..
08Jan Appointment of Director
Inter-alia considered and approved the following: (i) Appointment of Mr..
03Jan Wanbury completes Brazilian Health Aut
Wanbury has successfully completed the Brazilian Health Authority (ANVIS..
20Dec Wanbury informs about press release
Wanbury has informed that pursuant to Regulation 30 (6) of $EBI (Listing..
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit12.1800000000004304
Gross Profit 12.9200000000004 307.81
Operating Profit 147.82729.93
Net Sales 1334.525756.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Torrent Pharma (BSE)
 3284.75 (1.08%)
M.Cap ( in Cr)
111170.87
Mankind Pharma (BSE)
 2450.40 (0.93%)
M.Cap ( in Cr)
101098.24
Bal Pharma (BSE)
 121.70 (11.61%)
M.Cap ( in Cr)
193.81
Sanofi India (BSE)
 6011.35 (0.19%)
M.Cap ( in Cr)
13844.51
Source Natural Foods (BSE)
 193.95 (3.11%)
M.Cap ( in Cr)
124.84
Shareholding Pattern
NON-INSTITUTION 59.4%
PROMOTERS 39.76%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX75364.69-930.67 (-1.22%)
NIFTY22904.45-345.65 (-1.49%)
Dow Jones 38314.86-2231.07 (-5.50%)
Nasdaq 15587.79-962.82 (-5.82%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI